Advanced Filters
noise

Coronary Artery Disease Clinical Trials

A listing of Coronary Artery Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 520 clinical trials
W Wenfei He

MCG is Clinically Applied to Evaluate Myocardial Ischemic Function in Patients With Stable Coronary Artery Disease

The objective of this observational study is to evaluate the diagnostic effectiveness of magnetocardiography (MCG) in patients with stable coronary artery disease (SCAD) and compare it with coronary CTA (CCTA). Additionally, the study aims to determine the most suitable diagnostic index for MCG. The primary question it seeks to address …

18 years of age All Phase N/A
H Hilde Vandenhoutte, PhD

Data Collection for CAD Evaluation

Mammographical data collection (raw data) for CAD evaluation by VUCOMp software.

years of age Female Phase N/A
E Erik S. G. Stroes, MD, PhD

Plaque Reversal With Early, Aggressive Lipid Lowering Therapy

This study evaluates whether plaques in young patients with familial hypercholesterolemia (aged below 50 years) are susceptible to significant plaque regression with early, intensive lipid lowering therapy.

18 - 50 years of age All Phase N/A
L Lin Zhang, M.D.

PRogression of Atheroma Evaluated by CT Angiography and IntraCoronary Imaging tEchniques

This is a combined cohort study with retrospectively and prospectively enrolled coronary artery disease (CAD) patients. All the patients will undergo clinical follow-up for up to 5 years, and repeat coronary CTA will be conducted after 2 years. Comprehensive morphological and functional plaque analysis will be performed. The impact of …

18 years of age All Phase N/A
S Simone Biscaglia, MD

Scaffold in Emilia Romagna and in the MAGIC Network

The prospective study will investigate the clinical performance and long-term safety of scaffold implantation in a real world regional setting. The protocol includes two different networks. The first network includes all cath-labs in the Emilia-Romagna region (SHERPA). The second includes the centers partecipating into the MAGIC retrospective study. Both networks …

18 years of age All Phase N/A
N Neng Dai, MD

CHART Study of Coronary CT Angiography in Coronary Artery Disease

In a cohort of patients referred to coronary computed tomography angiography (CCTA), the investigators aim: To describe the natural history of the coronary atherosclerotic plaque development and progression or regression, as well as the plaque characterization and phenotypes over time by CCTA among deferred coronary lesions To explore the precursors …

18 years of age All Phase N/A

Clinical Outcomes of Patients Undergoing CABG Surgery With VEST Supported Venous Grafts

This is a prospective, investigator-initiated, multi-center, open label and post-market registry, enrolling patients with atherosclerotic coronary artery disease, scheduled for CABG with at least one SVG bypass. The registry is designed to evaluate the clinical outcome of CABG surgery with an external support device (VEST) for SVG bypasses. In each …

18 years of age All Phase N/A

Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study

The purpose of this study is to evaluate the prognosis of coronary stenosis based on intracoronary Imaging.

19 years of age All Phase N/A
C Cheol Ung Choi, M.D., Ph.D.

Gangwon PCI Prospective Registry

Comparison of Biolimus-eluting stent, Biomatrix, or Biomatrix Flex stent, Biosensors, Singapore Everolimus-eluting stent, Xience V, or Xience Prime, or Xience Xpedition stent, Abbott, USA Zotarolimus-eluting stent, Endeavor Resolute, or Endeavor Resolute Integrity stent Medtronic, USA in patients with coronary artery disease treated with percutaneous coronary intervention

19 years of age All Phase N/A
S Seung-Jung Park, MD,PhD

Study of the Natural History of FFR Guided Percutaneous Coronary Intervention

About 15,000 patients with FFR (Fractional Flow Reserve) will be enrolled and evaluated for the natural history of coronary lesions at 2 years clinical and imaging follow-up.

35 years of age All Phase N/A

Simplify language using AI